Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBRAM.L Regulatory News (BRAM)

  • There is currently no data for BRAM

Form 8 (OPD) - Brammer plc

24 Nov 2016 11:03

Maitland Institutional Services Ltd - Form 8 (OPD) - Brammer plc

Maitland Institutional Services Ltd - Form 8 (OPD) - Brammer plc

PR Newswire

London, November 24

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Amendment made to Section 2

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:MI Chelverton UK Equity Income Fund
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.Chelverton Asset Management
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeBrammer plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure23 November 2016
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:Ordinary 20p shares
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:2,380,7661.84%
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:2,380,7661.84%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?No

Date of disclosure:24/11/2016
Contact name:George Bayer, Maitland Administration Services Limited, Corporate Secretary
Telephone number:01245398984

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
29th Jul 20162:29 pmRNSDirectorate Change
29th Jul 201610:07 amRNSDirector Declaration
6th Jul 201612:48 pmRNSDirectorate Change
4th Jul 20163:04 pmRNSBlock listing Interim Review
1st Jul 201612:05 pmRNSHolding(s) in Company
1st Jul 201611:52 amRNSHolding(s) in Company
30th Jun 20165:39 pmRNSHolding(s) in Company
30th Jun 201610:28 amRNSHolding(s) in Company
29th Jun 20167:00 amRNSTrading Update
1st Jun 201611:39 amRNSDirectorate
31st May 20162:22 pmRNSHolding(s) in Company
13th May 20161:43 pmRNSResult of AGM
13th May 20167:00 amRNSAnnual General Meeting Trading Update
4th May 201610:18 amRNSHolding(s) in Company
4th Apr 20164:51 pmRNSDirector/PDMR Shareholding
31st Mar 201611:36 amRNSHolding(s) in Company
24th Mar 20163:39 pmRNSAnnual Financial Report
17th Mar 20163:43 pmRNSDirector/PDMR Shareholding
15th Mar 20163:51 pmRNSDirector/PDMR Shareholding
9th Mar 20163:33 pmRNSDirector/PDMR Shareholding
9th Mar 201610:26 amRNSDividend Payment
8th Mar 20167:02 amRNSAppointment of New Executive Director
8th Mar 20167:01 amRNSAppointment of Group Finance Director
8th Mar 20167:00 amRNSPreliminary Results
25th Feb 201611:56 amRNSDirector Declaration
16th Feb 201611:16 amRNSHolding(s) in Company
12th Feb 201611:58 amRNSHolding(s) in Company
20th Jan 20165:08 pmRNSHolding(s) in Company
19th Jan 20167:00 amRNSNotice of Results
12th Jan 20162:50 pmRNSHolding(s) in Company
7th Jan 20163:18 pmRNSHolding(s) in Company
7th Jan 201611:54 amRNSHolding(s) in Company
5th Jan 201610:01 amRNSBlocklisting Interim Review
4th Jan 201610:34 amRNSHolding(s) in Company
24th Dec 20151:15 pmRNSDirector/PDMR Shareholding
23rd Dec 201510:40 amRNSDirector/PDMR Shareholding
21st Dec 201510:00 amRNSHolding(s) in Company
16th Dec 20154:38 pmRNSDirectorate Change
9th Dec 201510:10 amRNSDirector/PDMR Shareholding
4th Dec 20153:00 pmRNSHolding(s) in Company
2nd Dec 201512:22 pmRNSHolding(s) in Company
27th Nov 20154:02 pmRNSHolding(s) in Company
20th Nov 20155:13 pmRNSDirector/PDMR Shareholding
11th Nov 20157:00 amRNSTrading Update
9th Nov 20152:40 pmRNSHolding(s) in Company
4th Nov 20152:11 pmRNSHolding(s) in Company
2nd Nov 201511:05 amRNSHolding(s) in Company
27th Oct 201511:39 amRNSDirector/PDMR Shareholding
13th Aug 20152:39 pmRNSDirector/PDMR Shareholding
13th Aug 20159:45 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.